BiotechTube

Moisturizer A, F#9155-005

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Skin

Conditions

Skin, Skin Care, Skin Cream

Trial Timeline

Oct 23, 2015 → Apr 7, 2016

NCT ID
NCT04510103

About Moisturizer A, F#9155-005

Moisturizer A, F#9155-005 is a pre-clinical stage product being developed by Johnson & Johnson for Skin. The current trial status is completed. This product is registered under clinical trial identifier NCT04510103. Target conditions include Skin, Skin Care, Skin Cream.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT04510103Pre-clinicalCompleted

Competing Products

20 competing products in Skin

See all competitors
ProductCompanyStageHype Score
[203Pb]VMT01 + [212Pb]VMT01 + NivolumabPerspective TherapeuticsPhase 1/2
33
[203Pb]VMT01 + [68Ga]VMT02Perspective TherapeuticsPhase 1
25
Mupirocin Calcium Cream, 2% + Bactroban® Cream + Cream vehicle of test productSun PharmaceuticalPhase 1
33
LY3041658 + PlaceboEli LillyPhase 1
33
DSP-9632P 27.5 mg + DSP-9632P 82.5 mg + Placebo + DSP-9632P 55.0 mg + Levodopa formulationSumitomo PharmaPhase 1
33
levofloxacinJohnson & JohnsonPhase 2/3
65
levofloxacinJohnson & JohnsonPhase 3
77
CeftobiproleJohnson & JohnsonPhase 1
33
Natural Killer Cell Therapy + Universal Donor Expanded TGF-beta-imprinted NK CellsJohnson & JohnsonPhase 1
33
LevofloxacinJohnson & JohnsonPhase 3
77
CeftobiproleJohnson & JohnsonPhase 1
33
Levodopa-carbidopa intestinal gelAbbViePhase 3
77
IressaAstraZenecaPhase 2
52
Daptomycin + VancomycinAstraZenecaPhase 3
77
SarizotanMerckPre-clinical
23
Pembrolizumab + EDP1503MerckPhase 2
52
testosterone gel + Comparator: placeboMerckPhase 1
33
LNS8801 + Pembrolizumab + Chemotherapy (dacarbazine or temozolomide) + Immunotherapy (Pembrolizumab) + Immunotherapy (nivolumab and relatlimab) + Immunotherapy (ipilimumab and nivolumab)MerckPhase 2/3
65
Vancomycin + Daptomycin + Semi-Synthetic PenicillinMerckApproved
85
Pembrolizumab + VismodegibMerckPhase 1/2
41

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85